Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy
- 9 November 2010
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 24 (12), 1386-1394
- https://doi.org/10.1111/j.1468-3083.2010.03647.x
Abstract
Background Psoriasis vulgaris is associated with overweight/obesity and with increased C‐reactive protein (CRP), tumour necrosis factor (TNF)‐α, interleukin (IL)‐6, leptin and resistin levels and decreased adiponectin levels. Objectives To understand the role/relationship of adipokines, as well as CRP, in a Portuguese psoriatic population, by assessing the relationship of their levels with psoriasis severity, defined by Psoriasis Area and Severity Index (PASI), with obesity, defined by body mass index (BMI), and psoriasis therapy. Methods A cross‐sectional (n = 66) and longitudinal study (before and after 12 weeks of therapy; n = 44) was performed; 10 patients started topical treatment, 17 narrow‐band ultraviolet B (NBUVB) and 17 psolaren associated with UVA (PUVA). Results Patients presented significantly higher BMI, leptin, resistin, TNF‐α, IL‐6 and CRP and significantly lower adiponectin values. CRP and IL‐6 correlated with PASI. Adiponectin and leptin were more altered in patients with higher BMI. Concerning severity, CRP, resistin and adiponectin were more altered in the severer forms. After treatment, a significant reduction in PASI, CRP, resistin, TNF‐α and IL‐6, and a significant rise in adiponectin were observed. Nonetheless, CRP and adiponectin remained different from those of control. Concerning therapies, topical therapy was not associated with any significant change, except for TNF‐α. After NBUVB, a significant reduction was observed in TNF‐α and in CRP. For PUVA, we observed a significant reduction in TNF‐α, IL‐6 and CRP, and a significant increase in adiponectin. Conclusion In psoriatic patients, increased overweight/obesity was associated with raised leptin levels and decreased adiponectin levels. Leptin may contribute to enhance the inflammatory process in overweight/obese psoriatic patients. Resistin, IL‐6, CRP and adiponectin levels appear to be dependent on psoriasis severity. CRP, together with IL‐6, appears to be a useful marker of psoriasis severity. Both NBUVB and PUVA were effective; however, PUVA results seem to be more successful. Nonetheless, after NBUVB and PUVA, a low‐grade inflammation still persists.Keywords
This publication has 40 references indexed in Scilit:
- Plasma adiponectin and leptin levels in Japanese patients with psoriasisBritish Journal of Dermatology, 2008
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008
- Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseasesClinical Science, 2008
- Alterations in plasma and tissue lipids associated with obesity and metabolic syndromeClinical Science, 2008
- Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and reviewBritish Journal of Dermatology, 2007
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Psoriasis is associated with lipid abnormalities at the onset of skin diseaseJournal of the American Academy of Dermatology, 2006
- The implication of obesity and central fat on markers of chronic inflammation: The ATTICA studyAtherosclerosis, 2005
- Prognostic Factor Analysis for Plaque PsoriasisDermatology, 2005
- Adipose tissue, adipokines, and inflammationJournal of Allergy and Clinical Immunology, 2005